C

Altamira Therapeutics Ltd
D

CYTO

0.45050
USD
0.03
(7.26%)
Market Open
Volume
100
EPS
0
Div Yield
0
P/E
0
Market Cap
1,702,225
News

Title: Altamira Therapeutics Ltd

Sector: Healthcare
Industry: Biotechnology
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray forpersonal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation.This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.